Objective To investigate the impact of incorrect specification of the working correlation structure matrix on estimated sample size in a 2×2 crossover design based on the generalized estimating equation (GEE). Methods Based on Monte Carlo simulation, the influence of incorrect specification of the work-related structure matrix on the sample size estimation under different conditions was evaluated after controlling the total sample size n, the proportion of subjects assigned to AB sequence (s=1) θ, the correlation coefficient ρ, and the placebo effect OR. Bias and mean square error (MSE) were used to assess the difference between the sample size estimates and the theoretical values. Results When the correctly specified working correlation structure matrix is independent, the sample size estimation effect of correctly specifying the working correlation structure matrix is better than that of incorrect specification. But when the correctly specified working correlation structure matrix is equal and the correlation coefficient is closer to 0, with other factors being smaller (n≤50, θ≤0.5, OR=2 in this article), there is a situation where the bias of the sample size estimation value for the correctly specified working correlation structure matrix is greater than the bias for the incorrectly specified working correlation structure matrix. Conclusion Under most conditions, incorrectly specifying the working correlation structure matrix can cause the estimated sample size to deviate significantly from the theoretical value, but under certain conditions, the impact of incorrectly specifying the working correlation structure matrix can be small on the estimated sample size.
HillsM, ArmitageP. The two-period cross-over clinical trial[J]. Brit J Clinical Pharma, 1979, 8(1): 7-20. doi:10.1111/j.1365-2125.1979.tb05903.x
[2]
LuiKJ, ChangKC. Test non-inferiority (and equivalence) based on the odds ratio under a simple crossover trial[J]. Stat Med, 2011, 30(11): 1230-42. doi:10.1002/sim.4166
[3]
LuiKJ. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial[J]. Pharm Stat, 2013, 12(2): 74-81. doi:10.1002/pst.1555
[4]
ChowSC, WangH. On sample size calculation in bioequivalence trials[J]. J Pharmacokinet Pharmacodyn, 2001, 28(2): 155-69. doi:10.1023/a:1011503032353
[5]
ChowSC, ChengB, CosmatosD. On power and sample size calculation for QT studies with recording replicates at given time point[J]. J Biopharm Stat, 2008, 18(3): 483-93. doi:10.1080/10543400801995452
[6]
SiyasingheNM, SooriyarachchiMR. Guidelines for calculating sample size in 2x2 crossover trials: a simulation study[J]. J Natl Sci Found Sri Lanka, 2011, 39(1): 77. doi:10.4038/jnsfsr.v39i1.2929
ZouGY, DonnerA. Extension of the modified Poisson regression model to prospective studies with correlated binary data[J]. Stat Methods Med Res, 2013, 22(6): 661-70. doi:10.1177/0962280211427759
[13]
FordWP, WestgatePM. A comparison of bias-corrected empirical covariance estimators with generalized estimating equations in small-sample longitudinal study settings[J]. Stat Med, 2018, 37(28): 4318-29. doi:10.1002/sim.7917
[14]
LiP, ReddenDT. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes[J]. Stat Med, 2015, 34(2): 281-96. doi:10.1002/sim.6344
[15]
PanW. Sample size and power calculations with correlated binary data[J]. Control Clin Trials, 2001, 22(3): 211-27. doi:10.1016/s0197-2456(01)00131-3
[16]
JungSH, AhnCW. Sample size for a two-group comparison of repeated binary measurements using GEE[J]. Stat Med, 2005, 24(17): 2583-96. doi:10.1002/sim.2136
[17]
KimHY, WilliamsonJM, LylesCM. Sample-size calculations for studies with correlated ordinal outcomes[J]. Stat Med, 2005, 24(19): 2977-87. doi:10.1002/sim.2162
[18]
ShihWJ. Sample size and power calculations for periodontal and other studies with clustered samples using the method of generalized estimating equations[J]. Biom J, 1997, 39(8): 899-908. doi:10.1002/bimj.4710390803
[19]
TeerenstraS, LuB, PreisserJS, et al. Sample size considerations for GEE analyses of three-level cluster randomized trials[J]. Biometrics, 2010, 66(4): 1230-7. doi:10.1111/j.1541-0420.2009.01374.x
[20]
LiF, ForbesAB, TurnerEL, et al. Power and sample size requirements for GEE analyses of cluster randomized crossover trials[J]. Stat Med, 2019, 38(4): 636-49. doi:10.1002/sim.7995
[21]
LiF, TurnerEL, PreisserJS. Sample size determination for GEE analyses of stepped wedge cluster randomized trials[J]. Biometrics, 2018, 74(4): 1450-8. doi:10.1111/biom.12918
[22]
LiF. Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure[J]. Stat Med, 2020, 39(4): 438-55. doi:10.1002/sim.8415
[23]
ZhangS, CaoJ, AhnC. A GEE approach to determine sample size for pre- and post-intervention experiments with dropout[J]. Comput Stat Data Anal, 2014, 69: 10.1016/j.csda.2013.07.037. doi:10.1016/j.csda.2013.07.037
[24]
TangYQ. Power and sample size for GEE analysis of incomplete paired outcomes in 2 × 2 crossover trials[J]. Pharm Stat, 2021, 20(4): 820-39. doi:10.1002/pst.2112
[25]
刘 凯. 基于广义估计方程样本量的计算[D]. 大连: 大连理工大学, 2020.
[26]
TangYQ. A noniterative sample size procedure for tests based on t distributions[J]. Stat Med, 2018, 37(22): 3197-213. doi:10.1002/sim.7807
[27]
SpiegelmanD, HertzmarkE. Easy SAS calculations for risk or prevalence ratios and differences[J]. Am J Epidemiol, 2005, 162(3): 199-200. doi:10.1093/aje/kwi188
[28]
ManclLA, DeRouenTA. A covariance estimator for GEE with improved small-sample properties[J]. Biometrics, 2001, 57(1): 126-34. doi:10.1111/j.0006-341x.2001.00126.x
[29]
KauermannG, CarrollRJ. A note on the efficiency of sandwich covariance matrix estimation[J]. J Am Stat Assoc, 2001, 96(456): 1387-96. doi:10.1198/016214501753382309
[30]
HuangYJ, PanJX. Joint generalized estimating equations for longitudinal binary data[J]. Comput Stat Data Anal, 2021, 155: 107110. doi:10.1016/j.csda.2020.107110
[31]
TsaiMY. Concordance correlation coefficients estimated by generalized estimating equations and variance components for longitudinal repeated measurements[J]. Stat Med, 2017, 36(8): 1319-33. doi:10.1002/sim.7207
[32]
JanseRJ, HoekstraT, JagerKJ, et al. Conducting correlation analysis: important limitations and pitfalls[J]. Clin Kidney J, 2021, 14(11): 2332-7. doi:10.1093/ckj/sfab085